KEAP1 and metabolic disease: The latest studies suggest that lower activity of the Nrf2-Keap1 system (“nuclear factor-erythroid-2-related factor 2” and “kelch-like ECH-associated protein 1”) is also associated with metabolic disease’s development [34].